Taicang, China – PerkinElmer officially inaugurated its expanded manufacturing and R&D facility in Taicang Suzhou, Jiangsu Province today. This milestone marks a significant advancement in the company’s “In China, For China – and Beyond” strategy, reinforcing its long-term commitment to the Chinese market. Situated in the heart of the Yangtze River Delta, the new state-of-the-art facility […]

LINCOLN, NE and Heidelberg, Germany – LICORbio, a leading innovator in life science imaging and analytical solutions, today announced the acquisition of SERVA Electrophoresis, a privately held company known for its high-quality electrophoresis reagents, consumables, and workflow instrumentation. The transaction strengthens LICORbio’s position as a comprehensive solutions provider in protein analysis and enhances its commitment to […]

Saint-Germain-en-Laye, France – Takara Bio Europe is pleased to announce it has entered into a distribution agreement with MACHEREY-NAGEL (MN), a leading global provider of analytical and bioanalytical products. Under this agreement, Takara Bio Europe will distribute MN’s Bioanalysis portfolio in Austria, Belgium, Denmark, France, Germany, Ireland, Luxemburg, Sweden, Switzerland and the United Kingdom. MN’s Bioanalysis […]

Financing to accelerate commercialization of flagship products, service business, and entrance into U.S. market STOCKHOLM — Epigenica AB, a pioneer in high-throughput epigenetic screening tools and solutions, announced today that it has closed a $2.2 million round (SEK 21.5M) to fuel its growth and commercial expansion across key markets. This round was led by Voima Ventures, a Nordic early-stage […]

WASHINGTON — Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Martin Stumpe will be appointed Chief Technology and AI Officer, effective October 1, 2025. He will report directly to Rainer Blair, President and Chief Executive Officer. This appointment marks a pivotal step in Danaher’s digital transformation and its ambition to lead the […]

WASHINGTON — Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Greg Milosevich has been appointed by its Board of Directors to be Executive Vice President of Danaher with responsibility for its Life Sciences business, effective July 1, 2025. Mr. Milosevich has served as Vice President and Group Executive of the […]

New instrument automates tissue processing for researchers in cancer, immunology and other science fields VANCOUVER, BRITISH COLUMBIA – To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. […]

Stephen H. Rusckowski elected as Chairman of the Supervisory Board after AGM; former Chairman Lawrence A. Rosen did not stand for re-election following 12 years of service Shareholders approve all resolutions at AGM – including first-ever annual cash dividend and a synthetic share repurchase authorization of up to $500 million VENLO, Netherlands — QIAGEN N.V. […]

Transaction Set to Close in July Synthego Solidly Positioned for Expansion & Growth Redwood City, CA — Synthego, a leading provider of CRISPR solutions, today confirmed that its sale to Perceptive Advisors, a global life sciences investor known for backing leading biotech companies, is cleared to close. This transaction, expected to close in July, will […]

Researchers aim to understand mechanisms of alternative splicing in neurodegenerative disease SEATTLE, United States — Parse Biosciences today announced their commitment to support researchers from the Icahn School of Medicine at Mount Sinai in generating one of the largest single cell datasets focused on understanding alternative splicing events in the cells of Alzheimer’s and Parkinson’s […]